These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 26575954)

  • 1. Catabolic pathways regulated by mTORC1 are pivotal for survival and growth of cancer cells expressing mutant Ras.
    Sung S; Choi J; Cheong H
    Oncotarget; 2015 Dec; 6(38):40405-17. PubMed ID: 26575954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ribonucleoprotein HNRNPA2B1 interacts with and regulates oncogenic KRAS in pancreatic ductal adenocarcinoma cells.
    Barceló C; Etchin J; Mansour MR; Sanda T; Ginesta MM; Sanchez-Arévalo Lobo VJ; Real FX; Capellà G; Estanyol JM; Jaumot M; Look AT; Agell N
    Gastroenterology; 2014 Oct; 147(4):882-892.e8. PubMed ID: 24998203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical KRAS
    Hobbs GA; Baker NM; Miermont AM; Thurman RD; Pierobon M; Tran TH; Anderson AO; Waters AM; Diehl JN; Papke B; Hodge RG; Klomp JE; Goodwin CM; DeLiberty JM; Wang J; Ng RWS; Gautam P; Bryant KL; Esposito D; Campbell SL; Petricoin EF; Simanshu DK; Aguirre AJ; Wolpin BM; Wennerberg K; Rudloff U; Cox AD; Der CJ
    Cancer Discov; 2020 Jan; 10(1):104-123. PubMed ID: 31649109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macropinocytosis Renders a Subset of Pancreatic Tumor Cells Resistant to mTOR Inhibition.
    Michalopoulou E; Auciello FR; Bulusu V; Strachan D; Campbell AD; Tait-Mulder J; Karim SA; Morton JP; Sansom OJ; Kamphorst JJ
    Cell Rep; 2020 Feb; 30(8):2729-2742.e4. PubMed ID: 32101748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. UBL4A inhibits autophagy-mediated proliferation and metastasis of pancreatic ductal adenocarcinoma via targeting LAMP1.
    Chen H; Li L; Hu J; Zhao Z; Ji L; Cheng C; Zhang G; Zhang T; Li Y; Chen H; Pan S; Sun B
    J Exp Clin Cancer Res; 2019 Jul; 38(1):297. PubMed ID: 31288830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. REP1 Modulates Autophagy and Macropinocytosis to Enhance Cancer Cell Survival.
    Choi J; Kim H; Bae YK; Cheong H
    Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28846638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A human cancer xenograft model utilizing normal pancreatic duct epithelial cells conditionally transformed with defined oncogenes.
    Inagawa Y; Yamada K; Yugawa T; Ohno S; Hiraoka N; Esaki M; Shibata T; Aoki K; Saya H; Kiyono T
    Carcinogenesis; 2014 Aug; 35(8):1840-6. PubMed ID: 24858378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of autophagy by coordinated action of mTORC1 and protein phosphatase 2A.
    Wong PM; Feng Y; Wang J; Shi R; Jiang X
    Nat Commun; 2015 Aug; 6():8048. PubMed ID: 26310906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A recombinantly tailored β-defensin that displays intensive macropinocytosis-mediated uptake exerting potent efficacy against K-Ras mutant pancreatic cancer.
    Du Y; Shang BY; Sheng WJ; Zhang SH; Li Y; Miao QF; Zhen YS
    Oncotarget; 2016 Sep; 7(36):58418-58434. PubMed ID: 27517152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CXCR2 signaling regulates KRAS(G¹²D)-induced autocrine growth of pancreatic cancer.
    Purohit A; Varney M; Rachagani S; Ouellette MM; Batra SK; Singh RK
    Oncotarget; 2016 Feb; 7(6):7280-96. PubMed ID: 26771140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional control of autophagy-lysosome function drives pancreatic cancer metabolism.
    Perera RM; Stoykova S; Nicolay BN; Ross KN; Fitamant J; Boukhali M; Lengrand J; Deshpande V; Selig MK; Ferrone CR; Settleman J; Stephanopoulos G; Dyson NJ; Zoncu R; Ramaswamy S; Haas W; Bardeesy N
    Nature; 2015 Aug; 524(7565):361-5. PubMed ID: 26168401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CXCL12-induced macropinocytosis modulates two distinct pathways to activate mTORC1 in macrophages.
    Pacitto R; Gaeta I; Swanson JA; Yoshida S
    J Leukoc Biol; 2017 Mar; 101(3):683-692. PubMed ID: 28250113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Utilization of Extracellular Proteins as Nutrients Is Suppressed by mTORC1.
    Palm W; Park Y; Wright K; Pavlova NN; Tuveson DA; Thompson CB
    Cell; 2015 Jul; 162(2):259-270. PubMed ID: 26144316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EGFR-Pak Signaling Selectively Regulates Glutamine Deprivation-Induced Macropinocytosis.
    Lee SW; Zhang Y; Jung M; Cruz N; Alas B; Commisso C
    Dev Cell; 2019 Aug; 50(3):381-392.e5. PubMed ID: 31257175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutated K-ras activates CDK8 to stimulate the epithelial-to-mesenchymal transition in pancreatic cancer in part via the Wnt/β-catenin signaling pathway.
    Xu W; Wang Z; Zhang W; Qian K; Li H; Kong D; Li Y; Tang Y
    Cancer Lett; 2015 Jan; 356(2 Pt B):613-27. PubMed ID: 25305448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CYRI-B-mediated macropinocytosis drives metastasis via lysophosphatidic acid receptor uptake.
    Nikolaou S; Juin A; Whitelaw JA; Paul NR; Fort L; Nixon C; Spence HJ; Bryson S; Machesky LM
    Elife; 2024 May; 13():. PubMed ID: 38712822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological inhibition of lysosomes activates the MTORC1 signaling pathway in chondrocytes in an autophagy-independent manner.
    Newton PT; Vuppalapati KK; Bouderlique T; Chagin AS
    Autophagy; 2015; 11(9):1594-607. PubMed ID: 26259639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KRAS: feeding pancreatic cancer proliferation.
    Bryant KL; Mancias JD; Kimmelman AC; Der CJ
    Trends Biochem Sci; 2014 Feb; 39(2):91-100. PubMed ID: 24388967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phellodendrine chloride suppresses proliferation of KRAS mutated pancreatic cancer cells through inhibition of nutrients uptake via macropinocytosis.
    Thu PM; Zheng ZG; Zhou YP; Wang YY; Zhang X; Jing D; Cheng HM; Li J; Li P; Xu X
    Eur J Pharmacol; 2019 May; 850():23-34. PubMed ID: 30716311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A subset of metastatic pancreatic ductal adenocarcinomas depends quantitatively on oncogenic Kras/Mek/Erk-induced hyperactive mTOR signalling.
    Kong B; Wu W; Cheng T; Schlitter AM; Qian C; Bruns P; Jian Z; Jäger C; Regel I; Raulefs S; Behler N; Irmler M; Beckers J; Friess H; Erkan M; Siveke JT; Tannapfel A; Hahn SA; Theis FJ; Esposito I; Kleeff J; Michalski CW
    Gut; 2016 Apr; 65(4):647-57. PubMed ID: 25601637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.